Intercept Pharmaceuticals INC
Doing business as C. T. CORPORATION SYSTEM (Previous Legal)
At a glance
Employees100-499
In business sinceNot reported
HeadquartersMorristown, NJ
US patents62
SAM.gov UEIGHNKCLBJRMK7
CAGE code7MWA6
Incorporated inDE
LEI254900JMB8TX5P688V24
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
62 US patents granted 2006–2025, 18 of them in the five years to SEP 2025.
Pharmaceuticals 44Organic fine chemistry 17
- Pharmaceutical compositions for combination therapyUS 12,337,003 · granted JUN 24, 2025
- Farnesoid X receptor modulatorsUS 12,291,549 · granted MAY 6, 2025
- TGR5 modulators and methods of use thereofUS 11,807,659 · granted NOV 7, 2023
- Isotopically labeled bile acid derivativesUS 11,472,831 · granted OCT 18, 2022
- Medicine obtained by combining FXR agonist and ARBUS 11,419,878 · granted AUG 23, 2022
Newest 5 shown · Granted to Intercept Pharmaceuticals, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Intercept Pharmaceuticals INC | Morristown | NJ | 100–499 | LIKELY ACTIVE |
WARN Act notices
- WARN notice effective FEB 28, 2026 · 146 employees · Intercept Pharmaceuticals INC
- WARN notice effective SEP 22, 2023 · 49 employees · Intercept Pharmaceuticals INC
Filed with the state under the federal WARN Act · WARN Act notices feed, CC BY 4.0
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.